LFVN

+ Watchlist + Portfolio

Lifevantage Corp.

Physical products Consumer brandTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $6.24
52-Week Range: $3.90 – $11.71
Market Cap: $76.42M
P/E (TTM): 15.18
EPS (TTM): 0.40
Dividend Yield: 3.29%

Advanced Metrics

Price/Book: 2.26
PEG Ratio: 0.36
Return on Equity: 14.87%
Return on Assets: 6.25%
Gross Margin: 77.56%
Operating Margin: 3.93%
Profit Margin: 2.78%
Current Ratio: 1.89
Debt/Equity: 0.29
Total Debt: $9.87M
Free Cash Flow: $6.00M
Revenue Growth: -23.10%
Earnings Growth: -32.80%
Enterprise Value: $70.99M

LFVN Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$206.36M	$213.40M	$200.16M	$228.53M	$182.59M
Cost of Revenue	$38.10M	$43.39M	$41.44M	$44.86M	$40.97M
Gross Profit	$168.26M	$170.01M	$158.72M	$183.67M	$141.61M
Selling, General & Admin	$63.42M	$71.06M	$68.47M	$69.21M	$58.42M
Operating Expenses	$160.69M	$165.75M	$154.39M	$171.47M	$135.51M
Operating Income	$7.58M	$4.26M	$4.33M	$12.20M	$6.10M
EBITDA	$7.96M	$7.84M	$7.91M	$15.36M	$8.87M
Pretax Income	$4.69M	$4.00M	$4.35M	$12.24M	$6.07M
Income Tax	$1.57M	$1.46M	$1.41M	$2.44M	$994.00K
Net Income	$3.12M	$2.54M	$2.94M	$9.80M	$5.07M
Diluted EPS	0.24	0.20	0.23	—	0.40
Diluted Shares	13.07M	12.57M	12.99M	—	12.70M

LFVN Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$20.19M	$21.61M	$16.89M	$20.20M	$14.92M
Receivables	$5.09M	$1.85M	$3.26M	$3.93M	$4.38M
Inventory	$16.47M	$16.07M	$15.05M	$20.67M	$16.17M
Current Assets	$46.96M	$44.28M	$37.65M	$50.89M	$38.30M
Total Assets	$70.71M	$66.12M	$60.30M	$71.96M	$62.11M
Current Liabilities	$25.73M	$19.61M	$22.31M	$27.22M	$20.23M
Total Debt	$15.76M	$13.09M	$13.61M	$11.68M	$9.87M
Total Liabilities	$39.19M	$31.47M	$34.31M	$37.32M	$28.52M
Retained Earnings	-$98.44M	—	—	—	-$103.46M
Shareholders' Equity	$31.52M	$34.65M	$25.99M	$34.64M	$33.59M
Working Capital	$21.23M	$24.68M	$15.34M	$23.68M	$18.07M

LFVN Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	$7.96M	$6.83M	$12.20M	$11.88M	$10.24M
Capital Expenditure	-$1.53M	-$3.07M	-$2.25M	-$1.37M	-$3.57M
Free Cash Flow	$6.43M	—	—	—	$6.67M
Depreciation & Amortisation	$3.26M	$3.58M	$3.58M	$3.16M	$2.77M
Stock-Based Compensation	$1.77M	$3.19M	$3.28M	$5.70M	$2.35M
Investing Cash Flow	-$1.53M	-$3.06M	-$2.25M	-$1.37M	-$7.31M
Financing Cash Flow	-$8.95M	-$2.36M	-$14.42M	-$7.60M	-$7.78M
Dividends Paid	-$378.00K	-$1.59M	-$6.94M	-$2.07M	-$2.34M
Share Repurchases	-$9.08M	-$1.02M	-$7.65M	-$5.81M	-$5.66M
Net Change in Cash	-$2.52M	$1.41M	-$4.46M	$2.91M	-$4.86M

LFVN Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$58.44M	$55.11M	$47.56M	$48.93M	$43.72M	$42.38M
Cost of Revenue	$11.11M	$11.06M	$9.74M	$12.72M	$9.17M	$9.33M
Gross Profit	$47.33M	$44.05M	$37.82M	$36.21M	$34.54M	$33.04M
Selling, General & Admin	$17.07M	$18.68M	$14.85M	$15.83M	$13.87M	$13.87M
Operating Expenses	$43.27M	$41.90M	$35.55M	$35.72M	$32.87M	$31.38M
Operating Income	$4.05M	$2.15M	$2.27M	$487.00K	$1.68M	$1.67M
EBITDA	$4.86M	$2.90M	$2.88M	$1.24M	$2.39M	$2.36M
Pretax Income	$4.18M	$2.40M	$2.24M	$473.00K	$1.66M	$1.70M
Income Tax	$710.00K	$437.00K	$86.00K	$197.00K	$294.00K	$417.00K
Net Income	$3.47M	$1.96M	$2.15M	$276.00K	$1.36M	$1.28M
Diluted EPS	0.26	0.15	0.17	0.02	0.11	0.10
Diluted Shares	13.30M	13.13M	12.95M	12.74M	12.66M	12.56M

LFVN Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$22.47M	$20.20M	$13.09M	$10.18M	$12.48M	$14.92M
Receivables	$3.24M	$3.93M	$7.72M	$4.98M	$4.62M	$4.38M
Inventory	$22.22M	$20.67M	$20.59M	$18.98M	$18.38M	$16.17M
Current Assets	$54.11M	$50.89M	$45.05M	$38.56M	$39.31M	$38.30M
Total Assets	$77.24M	$71.96M	$61.58M	$61.17M	$62.13M	$62.11M
Current Liabilities	$32.58M	$27.22M	$18.83M	$19.01M	$20.10M	$20.23M
Total Debt	$12.36M	$11.68M	$11.19M	$10.69M	$10.21M	$9.87M
Total Liabilities	$43.23M	$37.32M	$28.42M	$28.18M	$28.79M	$28.52M
Retained Earnings	-$103.51M	-$104.15M	-$103.14M	-$103.44M	-$103.66M	-$103.46M
Shareholders' Equity	$34.01M	$34.64M	$33.16M	$32.99M	$33.34M	$33.59M
Working Capital	$21.53M	$23.68M	$26.22M	$19.54M	$19.21M	$18.07M

LFVN Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$2.23M	$1.03M	-$2.31M	$2.79M	$4.99M	$4.77M
Capital Expenditure	-$331.00K	-$199.00K	-$439.00K	-$1.08M	-$1.01M	-$1.04M
Free Cash Flow	$1.90M	$835.00K	-$2.74M	$1.71M	$3.98M	$3.73M
Depreciation & Amortisation	$803.00K	$750.00K	$610.00K	$752.00K	$714.00K	$697.00K
Stock-Based Compensation	$1.52M	$1.54M	$826.00K	$553.00K	$704.00K	$263.00K
Investing Cash Flow	-$331.00K	-$199.00K	-$439.00K	-$4.83M	-$1.01M	-$1.04M
Financing Cash Flow	-$1.13M	-$3.24M	-$4.30M	-$738.00K	-$1.60M	-$1.15M
Dividends Paid	-$503.00K	-$562.00K	-$571.00K	-$575.00K	-$573.00K	-$625.00K
Share Repurchases	$1.25M	-$4.70M	-$3.86M	-$163.00K	$2.44M	-$4.08M
Net Change in Cash	$770.00K	-$2.41M	-$7.04M	-$2.77M	$2.38M	$2.58M

Market Snapshot

About

LifeVantage Corporation is a wellness company that focuses on nutrigenomics, the study of how nutrition and naturally occurring compounds affect genes. The company develops and distributes science-based products including dietary supplements, skin care, and wellness solutions. LifeVantage markets its products through a direct selling network of independent distributors globally.